Srinivasa Rao Kakani

Srinivasa Rao Kakani

Active Director Director DIN 03520250
DIN 03520250 First appointment Oct 2010 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 2 historical roles
Total affiliations 5 Since Oct 2010
Shareholding value •••• Premium profile

About Srinivasa Rao Kakani

Data last updated:

Srinivasa Rao Kakani is a Director at Biopil Life Care Private Limited (since 2024), Director at Orzal Industries Private Limited (since 2015) and Director at Synkorp Labs Limited (since 2020). The companies operate in Pharma and Consumer Goods. The 2 current companies with reported revenue have a combined latest revenue of ₹2.23 Cr; the largest is Biopil Life Care Private Limited at ₹2.23 Cr (FY 2024). Earlier, Srinivasa Rao Kakani was a Director at Brawn Laboratories Limited (2010–2011) and Director at Sereno Pharma Limited (from 2013).

DIN 03520250
Primary Designation Director
Industry Pharma
First Appointment 05 Oct 2010
Oldest Company Age 13 yrs
Largest company Biopil Life Care Private Limited · ₹2.23 Cr (FY 2024)
Combined revenue ₹2.23 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Biopil Life Care Private Limited U24239TG2021PTC153591
Director06 May 20242021₹2.23 Cr (FY 2024)Active
Orzal Industries Private Limited U74999DL2015PTC276888
Director19 Feb 20152015₹16,393 (FY 2023)Active
Synkorp Labs Limited U85100TG2020PLC139392
Director20 Feb 20202020Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Brawn Laboratories Limited U73200DL1990PLC039653
Director05 Oct 20101990₹369 Cr (FY 2025)Active
Sereno Pharma Limited U24232HR2013PLC049495
Director10 Jun 20132013₹1.47 Cr (FY 2016)Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Sereno Pharma Limited
Orzal Industries Private Limited
Synkorp Labs Limited
Biopil Life Care Private Limited
Premium access

Shareholding and investment profile for Srinivasa Rao Kakani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Srinivasa Rao Kakani

Srinivasa Rao Kakani currently holds 3 directorships: Biopil Life Care Private Limited (Director, since 06 May 2024, revenue ₹2.23 Cr (FY 2024)); Orzal Industries Private Limited (Director, since 19 Feb 2015, revenue ₹16,393 (FY 2023)); Synkorp Labs Limited (Director, since 20 Feb 2020).

Srinivasa Rao Kakani was first appointed on 05 Oct 2010 as Director at Brawn Laboratories Limited. The most recent appointment on record is 06 May 2024 at Biopil Life Care Private Limited.

The 2 current companies of Srinivasa Rao Kakani that report revenue have a combined latest revenue of ₹2.23 Cr: Biopil Life Care Private Limited ₹2.23 Cr (FY 2024); Orzal Industries Private Limited ₹16,393 (FY 2023).

Srinivasa Rao Kakani held 2 earlier board appointments: Brawn Laboratories Limited (Director, 05 Oct 2010 to 01 Dec 2011); Sereno Pharma Limited (Director, from 10 Jun 2013).

The current boards of Srinivasa Rao Kakani's companies include Anil Babu Korrapati (Biopil Life Care Private Limited), Majid Momeni (Orzal Industries Private Limited), Rajesh Kumar (Orzal Industries Private Limited), Zuhra Waheedurrehman Kuchi (Orzal Industries Private Limited), Satishbabu Yadlapalli (Synkorp Labs Limited), Suneetha Yadlapalli (Synkorp Labs Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available